Ethan Rowin to Predictive Value of Tests
This is a "connection" page, showing publications Ethan Rowin has written about Predictive Value of Tests.
Connection Strength
0.879
-
Rowin EJ, Maron BJ, Maron MS. The Hypertrophic Cardiomyopathy Phenotype Viewed Through the Prism?of?Multimodality Imaging: Clinical and Etiologic Implications. JACC Cardiovasc Imaging. 2020 09; 13(9):2002-2016.
Score: 0.135
-
Rowin EJ, Maron BJ, Olivotto I, Maron MS. Role of Exercise Testing in Hypertrophic?Cardiomyopathy. JACC Cardiovasc Imaging. 2017 11; 10(11):1374-1386.
Score: 0.117
-
Rowin EJ, Maron BJ, Appelbaum E, Link MS, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron MS. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol. 2012 Oct 01; 110(7):1027-32.
Score: 0.081
-
Rowin EJ, Maron MS, Lesser JR, Maron BJ. CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2012 Jan; 5(1):119-22.
Score: 0.078
-
Nakamori S, Rowin EJ, Rodriguez J, Ngo LH, Manning WJ, Maron M, Nezafat R. Accelerated myocardial fibrosis in young to middle-aged patients with hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2024 Winter; 26(2):101072.
Score: 0.047
-
Fahmy AS, Rowin EJ, Jaafar N, Chan RH, Rodriguez J, Nakamori S, Ngo LH, Pradella S, Zocchi C, Olivotto I, Manning WJ, Maron M, Nezafat R. Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value?of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. 2024 01; 17(1):16-27.
Score: 0.043
-
Fahmy AS, Rowin EJ, Arafati A, Al-Otaibi T, Maron MS, Nezafat R. Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2022 06 27; 24(1):40.
Score: 0.040
-
Mancio J, Pashakhanloo F, El-Rewaidy H, Jang J, Joshi G, Csecs I, Ngo L, Rowin E, Manning W, Maron M, Nezafat R. Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2022 03 22; 23(4):532-542.
Score: 0.040
-
Uretsky S, Aggarwal N, van Heeswijk RB, Rajpal S, Rowin E, Taylor MD, Verjans JW, Wokhlu A, Markl M, Raman SV, Shah DJ. Standards for writing Society for Cardiovascular Magnetic Resonance (SCMR) endorsed guidelines, expert consensus, and recommendations: a report of the publications committee. J Cardiovasc Magn Reson. 2021 11 04; 23(1):129.
Score: 0.039
-
Habib M, Adler A, Fardfini K, Hoss S, Hanneman K, Rowin EJ, Maron MS, Maron BJ, Rakowski H, Chan RH. Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study. JACC Cardiovasc Imaging. 2021 05; 14(5):947-958.
Score: 0.036
-
Uretsky S, Bangash A, Rowin E, Horgan S, Hiramatsu S, Lasam G, Gillam LD, Maron M. Determinants of LV Dilatation in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function: A CMR Study. JACC Cardiovasc Imaging. 2021 01; 14(1):298-300.
Score: 0.035
-
Vita T, Gr?ni C, Abbasi SA, Neilan TG, Rowin E, Kaneko K, Coelho-Filho O, Watanabe E, Mongeon FP, Farhad H, Rassi CH, Choi YL, Cheng K, Givertz MM, Blankstein R, Steigner M, Aghayev A, Jerosch-Herold M, Kwong RY. Comparing CMR Mapping Methods and?Myocardial Patterns Toward Heart?Failure Outcomes in Nonischemic?Dilated Cardiomyopathy. JACC Cardiovasc Imaging. 2019 08; 12(8 Pt 2):1659-1669.
Score: 0.031
-
Solomon Z, Breton C, Rowin EJ, Maron BJ, Maron MS, Chen FY, Rastegar H. Surgical Approaches to Hypertrophic Obstructive Cardiomyopathy. Semin Thorac Cardiovasc Surg. 2018; 30(2):125-128.
Score: 0.030
-
Maron MS, Rowin EJ, Maron BJ. How to Image Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2017 07; 10(7).
Score: 0.029
-
Weissler-Snir A, Hindieh W, Gruner C, Fourey D, Appelbaum E, Rowin E, Care M, Lesser JR, Haas TS, Udelson JE, Manning WJ, Olivotto I, Tomberli B, Maron BJ, Maron MS, Crean AM, Rakowski H, Chan RH. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (?-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2017 Feb; 10(2).
Score: 0.028
-
Weinstock J, Bader YH, Maron MS, Rowin EJ, Link MS. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience. J Am Heart Assoc. 2016 Feb 12; 5(2).
Score: 0.026
-
Kim J, Parikh P, Mahboob M, Arrighi JA, Atalay MK, Rowin EJ, Maron MS. Asymptomatic young man with Danon disease. Tex Heart Inst J. 2014 Jun; 41(3):332-4.
Score: 0.023
-
Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2014 Jan; 7(1):11-9.
Score: 0.022